Journals / Health Sciences Quarterly / 2021 / Cilt: 1 - Sayı: 2

An Evaluation of quantitative body composition on thoracic computed tomography and the effect on clinical severity in patients with chronic obstructive pulmonary disease

Pages
75–81
Publication Date
2021-07-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically significant difference was determined between the groups in respect of the SAT and MAT values (p=0.001, p=0.002, respectively).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to evaluate the effect on disease severity of the quantitative measurements of pectoral muscle area (PMA), pectoral muscle index (PMI), pectoral muscle density (PMD), subcutaneous adipose tissue (SAT) and mediastinal adipose tissue (MAT) taken on thoracic computed tomography (CT) of patients with chronic obstructive pulmonary disease (COPD), according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification.
📊
Key Findings & Data:The patients were grouped as A-B-C-D according to the GOLD 2018 guidelines.
💡
Conclusion & Impact:A statistically significant difference was determined between the groups in respect of the SAT and MAT values (p=0.001, p=0.002, respectively).
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:body composition · chronic obstructive pulmonary · disease

Abstract

The aim of this study was to evaluate the effect on disease severity of the quantitative measurements of pectoral muscle area (PMA), pectoral muscle index (PMI), pectoral muscle density (PMD), subcutaneous adipose tissue (SAT) and mediastinal adipose tissue (MAT) taken on thoracic computed tomography (CT) of patients with chronic obstructive pulmonary disease (COPD), according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. A retrospective screening was made of patients diagnosed with COPD and applied with thoracic CT and respiratory function tests. For patients with obstructive findings, a record was made of height, weight, body mass index, and smoking history (packet/year). On thoracic axial CT images, the PMA, PMI, PMD, SAT, and MAT values at the aortic arch level were calculated quantitatively using OsiriX software (Pixmeo, Switzerland). The patients were grouped as A-B-C-D according to the GOLD 2018 guidelines. Then two groups were formed as mild-moderate COPD (GOLD A-B) and severe COPD (GOLD C-D). The relationship was evaluated between clinical severity and quantitative body composition values according to the GOLD classification. A total of 80 patients diagnosed with COPD were included in the study comprising 61 males and 19 females. The GOLD A-B group included 43 (53.75%) patients and the GOLD C-D group, 37 (46.25%) patients. No significant difference was determined between the two groups in respect of the PMA, PMI, and PMD values (p=0.001). A statistically significant difference was determined between the groups in respect of the SAT and MAT values (p=0.001, p=0.002, respectively). A cutoff value of

🔖

Cite This Article

KAYA, F. (2021). An Evaluation of quantitative body composition on thoracic computed tomography and the effect on clinical severity in patients with chronic obstructive pulmonary disease. Health Sciences Quarterly, Cilt: 1 - Sayı: 2, 75–81. https://ajindex.com/articles/836571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Turner AM, Tamasi L, Schleich F, Hoxha M, Horvath I, Louis R, et al. Clinically relevant subgroups in COPD and asthma. Eur Respir Rev. 2015;24(136):283–298. https://doi.org/10.1183/16000617.00009014.
  2. Hruban RH, Meziane MA, Zerhouni EA, Khouri NF, Fishman EK, Wheeler PS, et al. High resolution computed tomography of inflation-fixed lungs. Pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis. 1987;136(4):935–940. https://doi.org/10.1164/ajrccm/136.4.935
  3. Sava F, Laviolette L, Bernard S, Breton MJ, Bourbeau J, Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010;10:55. https://doi.org/10.1186/1471-2466-10-55
  4. Rutten EP, Calverley PM, Casaburi R, Agusti A, Bakke P, Celli B, et al. Changes in body composition in patients with chronic obstructive Pulmonary disease: do they influence patient-related outcomes? Ann Nutr Metab. 2013;63:239–247. https://doi.org/10.1159/000353211
  5. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53–59. https://doi.org/10.1093/ajcn.82.1.53
  6. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809–813. https://doi.org/10.1164/rccm.2107031
  7. Romme EA, Murchison JT, Edwards LD, van Beek E Jr, Murchison DM, Rutten EP,et al. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res. 2013;28:1369–1377. https://doi.org/10.1002/jbmr.1873
  8. Diaz AA, Zhou L, Young TP, McDonald ML, Harmouche R, Ross JC, et al. Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers. Acad Radiol. 2014;21(10):1255-1261. https://doi.org/10.1016/j.acra.2014.05.013 van den Borst B, Gosker HR, Wesseling G, de Jager W, Hellwig VA, Snepvangers FJ, et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr. 2011;94:1504–1512. https://doi.org/10.3945/ajcn.111.023911
  9. Cho YH, Do KH, Chae EJ, Choi SH, Jo KW, Lee SO, et al. Association of Chest CT-Based Quantitative Measures of Muscle and Fat with Post-Lung Transplant Survival and Morbi